Skip to main content
logo
MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
14.94
-0.07 (-0.47%)
At close: Sep 8, 2026, 4:00 PM EDT
15.01
+0.07 (0.47%)
After-hours: Sep 8, 2026, 7:32 PM EDT

MLTX Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-263.67-227.32-118.94-36.01-49.97-64.37
Depreciation & Amortization
3.242.621.390.370.160.01
Asset Writedown & Restructuring Costs
-----5.82
Stock-Based Compensation
23.212.97.287.119.6510.86
Other Operating Activities
-0.95-4.08-2.53-8.03-14.160.09
Change in Accounts Receivable
-3.15-2.03-1.79-0.84-0.07-0.18
Change in Accounts Payable
-0.0420.567.161.58-1.311.88
Change in Other Net Operating Assets
16.21.34-9.15-6.96-0.23.68
Operating Cash Flow
-225.18-196.01-116.59-42.78-55.89-42.21
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--0.04-0.52-0.28-0.02-0.06
Investment in Securities
58.91203.03-205.08-24.9-32.32-
Investing Cash Flow
58.91202.99-205.6-25.18-32.34-0.06

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-73.02----
Total Debt Issued
24.4773.02---18
Short-Term Debt Repaid
-----15-
Total Debt Repaid
-----15-
Net Debt Issued (Repaid)
24.4773.02---1518
Issuance of Common Stock
313.6772.9852.78482.450.050.13
Repurchase of Common Stock
------0.01
Other Financing Activities
---1.47-2.75134.65-
Financing Cash Flow
338.1414651.31479.7119.6951.92

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.651.110.13-0.080.010
Net Cash Flow
171.22154.09-270.74411.6631.479.65

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-225.18-196.04-117.11-43.06-55.91-42.27
Free Cash Flow Growth
------
Free Cash Flow Per Share
-3.26-3.04-1.86-0.88-1.90-5.39
Levered Free Cash Flow
-131.86-120.38-92.06-24.14-32.23-
Unlevered Free Cash Flow
-125.55-115.85-92.06-24.14-32.23-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
7.865.06----
Cash Income Tax Paid
0.80.80.150.040-
Change in Working Capital
1319.88-3.78-6.22-1.585.38
SEC Filings: 10-K · 10-Q